Preclinical evaluation of non-imidazole histamine H3 receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia

The M1/M4 preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia

(2011) Segev Barak et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Differential effects of histamine H3 receptor inverse agonist thioperamide, given alone or in combination with the N-methyl-d-aspartate receptor antagonist dizocilpine, on reconsolidation and consolidation of a contextual fear memory in mice

(2011) Y. Charlier et al.   NEUROSCIENCE

Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: An overview of preclinical and clinical findings

(2011) Susanne Graef et al.   PSYCHOPHARMACOLOGY

The H3 antagonist, ciproxifan, alleviates the memory impairment but enhances the motor effects of MK-801 (dizocilpine) in rats

(2010) Mark E. Bardgett et al.   NEUROPHARMACOLOGY

Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists

(2010) Brooke M. Roberts et al.   PSYCHOPHARMACOLOGY

Gestational methylazoxymethanol acetate administration: A developmental disruption model of schizophrenia

(2009) Daniel J. Lodge et al.   BEHAVIOURAL BRAIN RESEARCH

Effect of pretreatment with risperidone on phencyclidine-induced disruptions in object recognition memory and prefrontal cortex parvalbumin immunoreactivity in the rat

(2009) Claire E. McKibben et al.   BEHAVIOURAL BRAIN RESEARCH

A Loss of Parvalbumin-Containing Interneurons Is Associated with Diminished Oscillatory Activity in an Animal Model of Schizophrenia

(2009) D. J. Lodge et al.   JOURNAL OF NEUROSCIENCE

Behavioral Perturbations After Prenatal Neurogenesis Disturbance in Female Rat

(2009) Franck Hazane et al.   NEUROTOXICITY RESEARCH

Effects of the H3 antagonist, thioperamide, on behavioral alterations induced by systemic MK-801 administration in rats

(2009) Mark E. Bardgett et al.   PSYCHOPHARMACOLOGY

The Neurodevelopmental Hypothesis of Schizophrenia, Revisited

(2009) S. H. Fatemi et al.   SCHIZOPHRENIA BULLETIN

The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia

(2008) Kuei Y. Tseng et al.   BEHAVIOURAL BRAIN RESEARCH

Identifying Cognitive Mechanisms Targeted for Treatment Development in Schizophrenia: An Overview of the First Meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative

(2008) Cameron S. Carter et al.   BIOLOGICAL PSYCHIATRY

The histamine H3receptor: an attractive target for the treatment of cognitive disorders

(2008) T A Esbenshade et al.   BRITISH JOURNAL OF PHARMACOLOGY

Selecting Paradigms From Cognitive Neuroscience for Translation into Use in Clinical Trials: Proceedings of the Third CNTRICS Meeting

(2008) D. M. Barch et al.   SCHIZOPHRENIA BULLETIN

Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats

(2007) T ENOMOTO et al.   BEHAVIOURAL BRAIN RESEARCH